Why do science ventures fail despite successful funding rounds? This article explains why confusing fundraising with capital acquisition quietly destroys scientific progress. It shows how capital treated as validation amplifies pressure instead of reducing uncertainty, why venture capital logic fails in science-driven innovation, and how capital sequencing, not storytelling, determines which ventures survive long term.